Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:23-28
Published online before print October 2, 2003, doi: 10.1161/01.ATV.0000097769.47306.12
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/1/23    most recent
01.ATV.0000097769.47306.12v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cathcart, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cathcart, M. K.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:23.)
© 2004 American Heart Association, Inc.


Brief Reviews

Regulation of Superoxide Anion Production by NADPH Oxidase in Monocytes/Macrophages

Contributions to Atherosclerosis

Martha K. Cathcart

From the Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, Ohio.

Correspondence to Martha K. Cathcart, PhD, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail cathcam{at}ccf.org

Series Editor: Marschall S. Runge
ATVB In Focus

Extracellular Mediators in Atherosclerosis and Thombosis

Previous Brief Review in this Series:

•Brasier AR, Recinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. 2002;22:1257–1266.
•Moser M. Patterson C. Thrombin and vascular development: a sticky subject. 2003;23:922–930.
•Major CD, Santulli RJ, Derian CK, Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. 2003;23:931–939.
•Yin Y-J, Salah Z, Grisaru-Granovsky S, Cohen I, Even-Ram SC, Maoz M, Uziely B, Peretz T, Bar-Shavit R. Human protese-activated receptor 1 expression in malignant epithelia: a role in invasiveness. 2003;23:940–944.
•Stouffer GA, Smyth SS. Effects of thrombin on interactions between ß3-integrins and extracellular matrix in platelets and vascular cells. 2003;23:1971–1978.

Monocyte extravasation into the vessel wall has been shown to be a critical step in the development of atherosclerosis. Upon activation, monocytes produce a burst of superoxide anion due to activation of the NADPH oxidase enzyme complex. Monocyte-derived superoxide anion contributes to oxidant stress in inflammatory sites, is required for monocyte-mediated LDL oxidation, and alters basic cell functions such as adhesion and proliferation. We hypothesize that monocyte-derived superoxide anion production contributes to atherosclerotic lesion formation. In this brief review, we summarize our current understanding of the signal transduction pathways regulating NADPH oxidase activation and related superoxide anion production in activated human monocytes. Novel pathways are identified that may serve as future targets for therapeutic intervention in this pathogenic process. The contributions of superoxide anion and NADPH oxidase to atherogenesis are discussed. Future experiments are needed to clarify the exact role of NADPH oxidase-derived superoxide anion in atherogenesis, particularly that derived from monocytes.


Key Words: monocyte • macrophage • superoxide anion • NADPH oxidase • atherosclerosis




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Lemarie, E. Bourdonnay, C. Morzadec, O. Fardel, and L. Vernhet
Inorganic Arsenic Activates Reduced NADPH Oxidase in Human Primary Macrophages through a Rho Kinase/p38 Kinase Pathway
J. Immunol., May 1, 2008; 180(9): 6010 - 6017.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Alipour, A. J.H. H.M van Oostrom, A. Izraeljan, C. Verseyden, J. M. Collins, K. N. Frayn, T. W.M. Plokker, J. W. F. Elte, and M. Castro Cabezas
Leukocyte Activation by Triglyceride-Rich Lipoproteins
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 792 - 797.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Jiang, N. Guo, and G. J. Dusting
Modulation of Nicotinamide Adenine Dinucleotide Phosphate Oxidase Expression and Function by 3',4'-Dihydroxyflavonol in Phagocytic and Vascular Cells
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Vendrov, Z. S. Hakim, N. R. Madamanchi, M. Rojas, C. Madamanchi, and M. S. Runge
Atherosclerosis Is Attenuated by Limiting Superoxide Generation in Both Macrophages and Vessel Wall Cells
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2714 - 2721.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Brizuela, M. Rabano, P. Gangoiti, N. Narbona, J. M. Macarulla, M. Trueba, and A. Gomez-Munoz
Sphingosine-1-phosphate stimulates aldosterone secretion through a mechanism involving the PI3K/PKB and MEK/ERK 1/2 pathways
J. Lipid Res., October 1, 2007; 48(10): 2264 - 2274.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. A. Gauss, L. K. Nelson-Overton, D. W. Siemsen, Y. Gao, F. R. DeLeo, and M. T. Quinn
Role of NF-{kappa}B in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-{alpha}
J. Leukoc. Biol., September 1, 2007; 82(3): 729 - 741.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Haurani and P. J. Pagano
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?
Cardiovasc Res, September 1, 2007; 75(4): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. P. Luyendyk, J. D. Piper, M. Tencati, K. V. Reddy, T. Holscher, R. Zhang, J. Luchoomun, X. Chen, W. Min, C. Kunsch, et al.
A Novel Class of Antioxidants Inhibit LPS Induction of Tissue Factor by Selective Inhibition of the Activation of ASK1 and MAP Kinases
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1857 - 1863.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Hryniewicz-Jankowska, P. K. Choudhary, and S. R. Goodman
Variation in the Monocyte Proteome
Experimental Biology and Medicine, July 1, 2007; 232(7): 967 - 976.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sugita, H. Sugita, and M. Kaneki
Farnesyltransferase Inhibitor, Manumycin A, Prevents Atherosclerosis Development and Reduces Oxidative Stress in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1390 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ikeda, A. Murakami, Y. Fujimura, H. Tachibana, K. Yamada, D. Masuda, K.-i. Hirano, S. Yamashita, and H. Ohigashi
Aggregated Ursolic Acid, a Natural Triterpenoid, Induces IL-1beta Release from Murine Peritoneal Macrophages: Role of CD36
J. Immunol., April 15, 2007; 178(8): 4854 - 4864.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. L. Figarola, N. Shanmugam, R. Natarajan, and S. Rahbar
Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes
Diabetes, March 1, 2007; 56(3): 647 - 655.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. KOLIAKOS, C. BEFANI, K. PALETAS, and M. KALOYIANNI
Effect of Endothelin on Sodium/Hydrogen Exchanger Activity of Human Monocytes and Atherosclerosis-Related Functions
Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 274 - 291.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Park, S. S. Choe, A H. Choi, K. H. Kim, M. J. Yoon, T. Suganami, Y. Ogawa, and J. B. Kim
Increase in Glucose-6-Phosphate Dehydrogenase in Adipocytes Stimulates Oxidative Stress and Inflammatory Signals
Diabetes, November 1, 2006; 55(11): 2939 - 2949.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-S. Wang, T. Lee, and S.-E. Chow
Role of exercise intensities in oxidized low-density lipoprotein-mediated redox status of monocyte in men
J Appl Physiol, September 1, 2006; 101(3): 740 - 744.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. Pignatelli, S. Di Santo, B. Buchetti, V. Sanguigni, A. Brunelli, and F. Violi
Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment
FASEB J, June 1, 2006; 20(8): 1082 - 1089.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
M. Sagi and R. Fluhr
Production of Reactive Oxygen Species by Plant NADPH Oxidases
Plant Physiology, June 1, 2006; 141(2): 336 - 340.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Anrather, G. Racchumi, and C. Iadecola
NF-{kappa}B Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91phox
J. Biol. Chem., March 3, 2006; 281(9): 5657 - 5667.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. J. Guzik, J. Sadowski, B. Guzik, A. Jopek, B. Kapelak, P. Przybylowski, K. Wierzbicki, R. Korbut, D. G. Harrison, and K. M. Channon
Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Fortuno, G. San Jose, M. U. Moreno, O. Beloqui, J. Diez, and G. Zalba
Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome
Diabetes, January 1, 2006; 55(1): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. E. Jalil, A. Perez, M. P. Ocaranza, J. Bargetto, A. Galaz, and S. Lavandero
Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme Levels
Hypertension, December 1, 2005; 46(6): 1362 - 1367.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Musiek, L. Gao, G. L. Milne, W. Han, M. B. Everhart, D. Wang, M. G. Backlund, R. N. DuBois, G. Zanoni, G. Vidari, et al.
Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages
J. Biol. Chem., October 21, 2005; 280(42): 35562 - 35570.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Zalba, O. Beloqui, G. S. Jose, M. U. Moreno, A. Fortuno, and J. Diez
NADPH Oxidase-Dependent Superoxide Production Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Atherosclerotic Disease
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1452 - 1457.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. A. Gauss, P. L. Bunger, T. C. Larson, C. J. Young, L. K. Nelson-Overton, D. W. Siemsen, and M. T. Quinn
Identification of a novel tumor necrosis factor {alpha}-responsive region in the NCF2 promoter
J. Leukoc. Biol., February 1, 2005; 77(2): 267 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calo, and A. Avogaro
Diabetes Induces p66shc Gene Expression in Human Peripheral Blood Mononuclear Cells: Relationship to Oxidative Stress
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. J. Barter, S. Nicholls, K.-A. Rye, G.M. Anantharamaiah, M. Navab, and A. M. Fogelman
Antiinflammatory Properties of HDL
Circ. Res., October 15, 2004; 95(8): 764 - 772.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev, October 1, 2004; 84(4): 1381 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Navab, G. M. Ananthramaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, G. C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, et al.
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
J. Lipid Res., June 1, 2004; 45(6): 993 - 1007.
[Abstract] [Full Text] [PDF]